ZetaFuse - Synthetic Small-Molecule

ZetaFuse is the first synthetic, small molecule, osteo-inductive biologic, to safely aid bone healing of spinal fusions. The U.S. Food and Drug Administration (FDA) has awarded ZetaFuse Breakthrough Device Designation[1] for the complete spinal column. ZetaFuse is driven by the activation of a novel molecular pathway, by leveraging this patented mechanism, to directly turn stem cells into osteoblasts (osteoinductive) and prevents bone resorption (anti-osteolytic).